JP2006525990A5 - - Google Patents

Download PDF

Info

Publication number
JP2006525990A5
JP2006525990A5 JP2006506603A JP2006506603A JP2006525990A5 JP 2006525990 A5 JP2006525990 A5 JP 2006525990A5 JP 2006506603 A JP2006506603 A JP 2006506603A JP 2006506603 A JP2006506603 A JP 2006506603A JP 2006525990 A5 JP2006525990 A5 JP 2006525990A5
Authority
JP
Japan
Prior art keywords
isoxazol
amide
phenyl
pentanoic acid
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006506603A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006525990A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2004/001478 external-priority patent/WO2004099200A1/en
Publication of JP2006525990A publication Critical patent/JP2006525990A/ja
Publication of JP2006525990A5 publication Critical patent/JP2006525990A5/ja
Withdrawn legal-status Critical Current

Links

JP2006506603A 2003-05-12 2004-05-10 神経変性障害の処置のためのイソオキサゾール化合物およびイソチアゾール化合物 Withdrawn JP2006525990A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47000203P 2003-05-12 2003-05-12
PCT/IB2004/001478 WO2004099200A1 (en) 2003-05-12 2004-05-10 Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders

Publications (2)

Publication Number Publication Date
JP2006525990A JP2006525990A (ja) 2006-11-16
JP2006525990A5 true JP2006525990A5 (https=) 2007-05-31

Family

ID=33435258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006506603A Withdrawn JP2006525990A (ja) 2003-05-12 2004-05-10 神経変性障害の処置のためのイソオキサゾール化合物およびイソチアゾール化合物

Country Status (7)

Country Link
US (1) US7241786B2 (https=)
EP (1) EP1636220A1 (https=)
JP (1) JP2006525990A (https=)
BR (1) BRPI0409721A (https=)
CA (1) CA2524511A1 (https=)
MX (1) MXPA05012196A (https=)
WO (1) WO2004099200A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
CN1934091B (zh) * 2004-03-23 2012-02-08 辉瑞产品公司 治疗神经变性障碍的咪唑化合物
US7220865B2 (en) * 2004-04-01 2007-05-22 Pfizer Inc Isoxazole-and isothiazole-amine compounds for the treatment of neurodegenerative disorders
US7244757B2 (en) * 2004-04-01 2007-07-17 Pfizer Inc Pyrazole-amine compounds for the treatment of neurodegenerative disorders
WO2007034326A2 (en) * 2005-09-22 2007-03-29 Pfizer Products Inc. Imidazole compounds for the treatment of neurological disorders
EP2081905B1 (en) 2006-07-28 2012-09-12 Boehringer Ingelheim International GmbH Sulfonyl compounds which modulate the cb2 receptor
CA2664310A1 (en) 2006-09-25 2008-04-03 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
JP5492092B2 (ja) 2007-11-07 2014-05-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb2受容体を調節する化合物
EP2265585B1 (en) * 2008-02-21 2014-09-17 Boehringer Ingelheim International GmbH Amine and ether compounds which modulate the cb2 receptor
EP2326629B1 (en) 2008-07-10 2013-10-02 Boehringer Ingelheim International GmbH Sulfone compounds which modulate the cb2 receptor
WO2010036630A2 (en) 2008-09-25 2010-04-01 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the cb2 receptor
WO2010096371A2 (en) 2009-02-18 2010-08-26 Boehringer Ingelheim International Gmbh Heterocyclic compounds which modulate the cb2 receptor
US8299103B2 (en) 2009-06-15 2012-10-30 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the CB2 receptor
JP5756800B2 (ja) 2009-06-16 2015-07-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb2受容体を調節するアゼチジン2−カルボキサミド誘導体
JP2013505295A (ja) 2009-09-22 2013-02-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb2受容体を選択的に調節する化合物
US9315454B2 (en) 2010-01-15 2016-04-19 Boehringer Ingelheim International Gmbh Compounds which modulate the CB2 receptor
EP2542539B1 (en) 2010-03-05 2014-02-26 Boehringer Ingelheim International GmbH Tetrazole compounds which selectively modulate the cb2 receptor
JP5746764B2 (ja) 2010-07-22 2015-07-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb2受容体を調節する化合物
AR091516A1 (es) 2012-06-22 2015-02-11 Actelion Pharmaceuticals Ltd Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida
EP2803668A1 (en) 2013-05-17 2014-11-19 Boehringer Ingelheim International Gmbh Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
GB201820166D0 (en) * 2018-12-11 2019-01-23 Ucb Biopharma Sprl Therapeutic agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0586537A4 (en) * 1991-05-28 1997-06-25 Merck & Co Inc Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
DE69329425T2 (de) * 1992-12-16 2001-01-18 Basf Ag Dolastatin analog
WO2000024392A1 (en) * 1998-10-26 2000-05-04 Sumitomo Pharmaceuticals Company, Limited β-AMYLOID FORMATION INHIBITORS
AR039059A1 (es) * 2001-08-06 2005-02-09 Sanofi Aventis Compuesto derivado de acilaminotiazol, su utilizacion, procedimientos para prepararlo, composicion farmaceutica que lo comprende, y compuestos intermediarios
WO2003064396A1 (en) * 2002-02-01 2003-08-07 Elan Pharmaceuticals, Inc. Hydroxyalkanoyl aminopyrazoles and related compounds
WO2004033434A1 (en) * 2002-10-09 2004-04-22 Pfizer Products Inc. Pyrazole compounds for treatment of neurodegenerative disorders
KR20050070046A (ko) * 2002-10-09 2005-07-05 화이자 프로덕츠 인크. 퇴행성신경 장애 치료를 위한 티아졸 화합물

Similar Documents

Publication Publication Date Title
JP2006525990A5 (https=)
CA2039056C (en) 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
EP1551815A1 (en) Thiazole compounds for the treatment of neurodegenerative disorders
RU2049784C1 (ru) Гетероциклические производные или их соли с кислотами или основаниями
KR20170082577A (ko) 치환된 피라졸로(1,5-a)피리미딘 및 의학적 장애의 치료에서의 그의 용도
JP2010501587A5 (https=)
WO2002102778A1 (en) Phenylpyridine carbonyl piperazine derivative
FR2587342A1 (fr) Nouveaux derives du thiazole, leur preparation et leur utilisation en therapeutique
KR20060132615A (ko) 시클로프로판 화합물 및 그의 약제학적 용도
JP2005509024A5 (https=)
RU2008136553A (ru) Производные бензотиазола в качестве агонистов бета2 адренорецептора
JPH01143856A (ja) 抗アレルギーおよび抗炎症剤用2−アリール置換複素環式化合物
RU2006137272A (ru) Производные 2-фенилпропионовой кислоты и содержащие их фармацевтические композиции
JPWO1998054153A1 (ja) 新規な環状ジアミン化合物及びこれを含有する医薬
EP3442948B1 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
JP2008506691A (ja) エストロゲン関連受容体−アルファに媒介される疾患の処置のためのアリーリデン
JP2020517677A5 (https=)
JP2007261945A (ja) チアゾール誘導体
FR2934995A1 (fr) Composes d'azetidines polysubstitues, leur preparation et leur application en therapeutique
WO2008150492A1 (en) Tricyclic inhibitors of fatty acid amide hydrolase
JP2006525990A (ja) 神経変性障害の処置のためのイソオキサゾール化合物およびイソチアゾール化合物
US5432179A (en) Piperazine derivatives and pharmaceuticals containing the same
JPWO2001036402A1 (ja) 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体
RU2007103304A (ru) Новые производные гексафторизопропанола
EP1627873A1 (en) Benzofuran compound and medicinal composition containing the same